Oxis International Stock OTC Bulletin Board
Equities
US6918295014
Pharmaceuticals
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.45M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.3
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.75% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Breen
CEO | Chief Executive Officer | 62 | 21-01-12 |
Manu Ohri
DFI | Director of Finance/CFO | 67 | 22-02-17 |
Jeffrey Miller
PRN | Corporate Officer/Principal | - | 22-12-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 23-04-30 | |
Bruce Wendel
BRD | Director/Board Member | 70 | 20-11-10 |
Rajesh Shrotriya
BRD | Director/Board Member | 79 | 21-01-12 |
1st Jan change | Capi. | |
---|---|---|
+32.91% | 690B | |
+26.43% | 546B | |
-5.06% | 358B | |
+18.57% | 323B | |
+4.61% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+3.84% | 161B |